Nico Corp. said today that it raised nearly $13 million in a Series B round from a group of existing backers for its line of neurosurgery devices.

Indianapolis-based Nico said the $12.5 million round is earmarked for new product development and commercialization, clinical and economic studies, growing its sales and clinical teams, and expanding its footprint in Europe.

Read full article from Mass Device here. 

“Injustice anywhere is a threat to justice everywhere...We are caught in an inescapable network of mutuality, tied in a single garment of destiny. Whatever affects one directly, affects all indirectly.” –MLK, Jr

Kicking things off at #AdobeSummit2019 with Partner Day! @AdobePartner @AdobeSummit #DialogTech

Ethically Designing Healthy Relationships
New Group Now Open for Enrollment in Durham!

This group helps participants explore polyamorous & consensual non-monogamous relationships.
https://t.co/k81HhIM8qX

We look forward to seeing everyone this week in #LasVegas! Don't forget to visit booth #967. If you would like to schedule a meeting with our team, you can send an email to events@dialogtech.com. #AdobeSummit #DialogTech #Voice